The Team



TPP Team Photo SF 2015 - low res

With an experienced team of well-connected industry veterans from all over the globe, TPP has the background, credentials, and understanding to execute and support transactions involving pharmaceuticals, medical devices, diagnostics, and therapeutics.

  • All
  • Advisors
  • Analysts
  • Founding Partners
  • Partners
  • Venture Partners
Tony Chu
Founding Partner
Tony has over 20 years of experience in the US/EU and Chinese chemical and pharmaceutical industries. Previously, he was CEO of Eastar Chemical Corp.
Asa Cox
Founding Partner
Asa is Founder & CEO of Generic Pharma 2.0 and genericlicensing.com. He has been globally connected since 1997 with a network of over 20,000 companies.
James Bruno
Partner, US
James was previously President of Drug Chemical & Allied Technologies Association (DCAT) and a senior executive at Honeywell, Vinchem, Aerojet, and Sipsy Chemical.
Amiram Katzman
Partner, EMEA
Amiram is currently the Managing Director of Prodan Capital Partners of Israel.  Previously he held senior positions in the Israeli bureaus for national security and healthcare.
Lisa Grant
Partner, US
Lisa is an award-winning manager with 30 years of experience within the cholesterol, respiratory, osteoporosis, and diabetic markets; most notably for Merck, Sanofi-Aventis, and Genentech, a division of Roche.
Heather McMills
Partner, China
Heather's capital markets and trustee experience spans almost 20 years, with stints at Credit Suisse and Bank of America, managing $400M in assets. As VP Global Strategy for Airware Labs Corp., China, she is responsible for research, corporate development, and strategic initiatives.
Ramlan Ibrahim
Partner, Asia Pacific
Ramlan has 20 years of experience in pharmaceutical and healthcare in the ASEAN market. He was previously Senior General Manager of Global Sales & Marketing at Pharmaniaga.
Mohd Zul Efendi
Partner, Asia Pacific
Mohd has spent 15 years in the ASEAN healthcare industry, including his previous positions as Senior Manager and Head of Business Development at Pharmaniaga Berhad and BD Director at Biosis Group Berhad.
Sean Jiang
Partner, China
Sean has 15 years of experience in investment banking, M&A, and PE/VC investment, having executed 100+ transactions and related engagements. He is Founder of Yafo Capital and was formerly General Manager of ISI (China) and Managing Director of ISI Group (US). Sean holds an MBA from Pepperdine University, MA in finance from Fudan University, and BA in Economics from Central South University.
Jonathan Myers
Venture Partner, China
Jonathan has over 17 years of experience in VC fundraising and pharma/biotech transactions. Jonathan was Founder and Managing Director of Nine Bridges Capital. Jonathan holds an MBA from the Rotterdam School of Management, Erasmus University and a BSc degree in Chemical Engineering from Michigan State University.
Lu Zhou
Venture Partner, China
Lu holds a PhD in Mathematics from the US. He has 10 years of experience in VC/PE healthcare investment as Principal, Managing Director, and Partner at CITIC Capital and Dragonrise Capital and has connected with a wide range of major financial institutions and pharmaceutical firms in China.
Jose Luis Fabregas
Venture Partner, EMEA
Jose previously held senior positions at Almirall, S.A, including roles as Senior Director of Pharma Development and a permanent member of the R&D Management Committee.
Hanspeter Trippmacher
Venture Partner, EMEA
Hanspeter was previously Executive Director and Board member of CABB Switzerland (former SF-Chem) as well as Global Sales Manager of Lonza Switzerland.
Charles Chu
Advisor, China
Charles has over 40 years of experience in both Chinese and US chemical industries. He was previously Senior Director at Jilin Chemical (now part of PetroChina) and Guangdong agricultural ministry. He founded Eastar Chemical Corporation, where he now serves as Chairman.
George Chu
Advisor, China
George has over 15 years of experience in the US/EU and Chinese chemical and pharmaceutical industries. He held the role of CFO of Eastar Chemical beginning in 2006 and has been CEO since 2008.
Terry Mo
Advisor, US
Terry has over 25 years of experience in managing China strategies and cross-border deals as senior executive for GE Plastics, Olin, Praxair, FMC, Great Lakes, and Motorola.
Peter Bigelow
Advisor, US
Peter was formerly CEO of Qualitest Generics Inc, US President of Patheon, and Global Head of Wyeth Consumer Healthcare.
Eric Huang
Advisor, China
Eric has over 25 years of experience in the medical field, which includes time spent at Johnson & Johnson Medical China, Boston Scientific, Medtronic China, and Sanofi China Pharmaceutical. Eric currently serves as Co-Founder and CMO at LenoMed, Co-President at Zhejiang POCTech Medical, and Founder and Chairman at Beijing InnoTech Medical.
James Han
Advisor, China
James has 30 years of industry experience ranging from chemicals and plastics to telecommunication, biotechnology, and medical devices. James currently serves as Founder and CEO of LenoMed and has served as Chairman, CEO, Founder, or President at Hanex Medical, Maxus Medical, Advanced Biomedical Technology, Kinetic Medical, and several other companies.
Derrick Li
Director of Investing & Licensing, US
Derrick was previously an equity research analyst for the Royce Funds, a $45 billion mutual fund and hedge fund based in New York City and focused on micro-cap and small-cap securities. Derrick holds degrees in both Finance and Accounting.
Rob Baranowski
Analyst, US
Rob previously worked as a credit derivatives trader at Deutsche Bank and has also helped build a successful proprietary algorithmic trading firm in the foreign exchange markets. He holds a B.S. in Mechanical Engineering from MIT.